{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:37:23Z","timestamp":1777639043480,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Russian Federation Government","award":["14.W03.031.0025"],"award-info":[{"award-number":["14.W03.031.0025"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111642","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T15:23:14Z","timestamp":1566832994000},"page":"111642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction"],"prefix":"10.1016","volume":"182","author":[{"given":"Stanislav","family":"Kalinin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Sharoyko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana B.","family":"Tennikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0200-4772","authenticated-orcid":false,"given":"Mikhail","family":"Krasavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111642_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2019.111642_bib2","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111642_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4155\/fmc.11.69","article-title":"Carbonic anhydrase inhibitors and activators for novel therapeutic applications","volume":"3","author":"Supuran","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111642_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138161208783877866","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111642_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","volume":"75","author":"Scozzafava","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2019.111642_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111642_bib8","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.bmc.2017.02.018","article-title":"Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3-and 4-(hetero)arylisoxazol-5-amine scaffolds","volume":"25","author":"Krasavin","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14756366.2016.1178248","article-title":"Isoform-selective inhibitory profile of 2-imidazoline-substituted benzenesulfonamides against a panel of human carbonic anhydrases","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib10","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/acs.jmedchem.5b01144","article-title":"Discovery of 1,1\u2032-Biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase XIV inhibitors","volume":"58","author":"La Regina","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib11","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.bmc.2017.04.007","article-title":"N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII","volume":"25","author":"Ivanova","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and Carbonic Anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib13","series-title":"Phase II Study for Metastatic Pancreatic Ductal Adenocarcinoma in Combination with Gemcitabine Anticancer Drug Is Scheduled to Be Completed in May 2022, According to","year":"2019"},{"key":"10.1016\/j.ejmech.2019.111642_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111642_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/17425255.2.1.113","article-title":"A\u00a0perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors","volume":"2","author":"Clare","year":"2006","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111642_bib16","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1523\/JNEUROSCI.20-22-08247.2000","article-title":"Interstitial carbonic anhydrase (CA) activity in brain is attributable to membrane-bound CA type IV","volume":"20","author":"Tong","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.111642_bib17","series-title":"Glial Physiology and Pathophysiology","first-page":"93","article-title":"Numbers: how many glial cells are in the brain?","author":"Verkhratsky","year":"2013"},{"key":"10.1016\/j.ejmech.2019.111642_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/glia.10187","article-title":"Surface carbonic anhydrase activity on astrocytes and neurons facilitates lactate transport","volume":"41","author":"Svichar","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2019.111642_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20277","article-title":"Functional demonstration of surface carbonic anhydrase IV activity on rat astrocytes","volume":"53","author":"Svichar","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2019.111642_bib20","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1113\/jphysiol.2011.220152","article-title":"Lactate flux in astrocytes is enhanced by a non-catalytic action of carbonic anhydrase II","volume":"590","author":"Stridh","year":"2012","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2019.111642_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1074\/jbc.RA118.005536","article-title":"Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70","volume":"294","author":"Forero-Quintero","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/138920211795860107","article-title":"Retinitis pigmentosa: genes and disease mechanisms","volume":"12","author":"Ferrari","year":"2011","journal-title":"Curr. Genom."},{"key":"10.1016\/j.ejmech.2019.111642_bib23","series-title":"Carbonic Anhydrases as Biocatalysts","first-page":"109","article-title":"Carbonic anhydrase IV","author":"Waheed","year":"2015"},{"issue":"05","key":"10.1016\/j.ejmech.2019.111642_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111642_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bioorg.2017.11.014","article-title":"Unprotected primary sulfonamide group facilitates ring-forming cascade en route to polycyclic [1.4]oxazepine-based carbonic anhydrase inhibitors","volume":"76","author":"Sapegin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/14756366.2017.1344236","article-title":"Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases","volume":"32","author":"Krasavin","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.03.030","article-title":"Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors","volume":"150","author":"Vats","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bmc.2016.11.027","article-title":"Discovery of 4-sulfamoyl-phenyl-\u03b2-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: the first example of subnanomolar CA IV inhibitors","volume":"25","author":"Angapelly","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib29","first-page":"31","article-title":"Catalytic mechanism of \u03b1-class carbonic anhydrases: CO2 hydration and proton transfer, Sub-cell","volume":"75","author":"Boone","year":"2014","journal-title":"Biochem"},{"key":"10.1016\/j.ejmech.2019.111642_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejmech.2018.11.073","article-title":"Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety","volume":"163","author":"Buemi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib31","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/jm00132a003","article-title":"Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma","volume":"32","author":"Baldwin","year":"1989","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/cr960370z","article-title":"Molecular recognition of Protein\u2212Ligand complexes: applications to drug design","volume":"97","author":"Babine","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111642_bib33","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1021\/jm0600287","article-title":"Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX","volume":"49","author":"Thiry","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bmc.2008.11.071","article-title":"Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors","volume":"17","author":"Thiry","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib35","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.2174\/138161210793429805","article-title":"3-Phenyl-1H-Indole-5-Sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors","volume":"16","author":"Guzela","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111642_bib36","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1016\/j.bmc.2010.09.007","article-title":"Chemistry Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors","volume":"18","author":"Gluszok","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib37","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","volume":"ID453543","author":"Pinard","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2019.111642_bib38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acsmedchemlett.7b00300","article-title":"Lucky switcheroo: dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII","volume":"8","author":"Kalinin","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111642_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib40","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/14756366.2017.1344236","article-title":"Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases","volume":"32","author":"Krasavin","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bioorg.2017.10.005","article-title":"Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms","volume":"76","author":"Krasavin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chempr.2017.01.011","article-title":"Fluorescence-based assay for carbonic anhydrase inhibitors","volume":"2","author":"Koutnik","year":"2017","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2019.111642_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-018-0653-9","article-title":"Development of a high throughput yeast-based screening assay for human carbonic anhydrase isozyme II inhibitors","volume":"8","author":"Sangkaew","year":"2018","journal-title":"Amb. Express"},{"key":"10.1016\/j.ejmech.2019.111642_bib44","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib45","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/cr100233r","article-title":"Chemistry and biology of multicomponent reactions","volume":"112","author":"D\u00f6mling","year":"2010","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111642_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14756366.2016.1220944","article-title":"Multicomponent chemistry in the synthesis of carbonic anhydrase inhibitors","volume":"31","author":"Kalinin","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib47","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1021\/jo00821a029","article-title":"Condensation of succinic anhydrides with Schiff bases. Scope and mechanism","volume":"36","author":"Castagnoli","year":"1971","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib48","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.bmc.2018.04.036","article-title":"Design, in silico prioritization and biological profiling of apoptosis-inducing lactams amenable by the Castagnoli-Cushman reaction","volume":"26","author":"Krasavin","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib49","doi-asserted-by":"crossref","first-page":"49411","DOI":"10.1039\/C6RA10249B","article-title":"The rare cis-configured trisubstitututed lactam products obtained by the Castagnoli-Cushman reaction in N,N-dimethylformamide","volume":"6","author":"Dar'in","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111642_bib50","doi-asserted-by":"crossref","first-page":"83808","DOI":"10.1039\/C6RA19196G","article-title":"The first solvent-free synthesis of privileged \u03b3- and \u03b4-lactams via the Castagnoli-Cushman reaction","volume":"6","author":"Lepikhina","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111642_bib51","first-page":"328189","article-title":"Preparation of N-benzoyl-4-sulfamoylbenzenesulfonamide derivatives as inhibitors of long chain fatty acid family 6 elongase","volume":"155","author":"Tawaraishi","year":"2011","journal-title":"PCT Int. Appl. WO 2011102514; Chem. Abstr."},{"key":"10.1016\/j.ejmech.2019.111642_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genhenden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111642_bib53","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1016\/j.bmc.2017.06.054","article-title":"1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: potency is supported by X-ray crystallography of two leads","volume":"25","author":"Ferraroni","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2407-10-148","article-title":"The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis","volume":"10","author":"Nordfors","year":"2009","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejmech.2019.111642_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"issue":"6352","key":"10.1016\/j.ejmech.2019.111642_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A\u00a0pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.111642_bib57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.ejmech.2019.111642_bib58","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"11","key":"10.1016\/j.ejmech.2019.111642_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207417","article-title":"Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: disconnect between activity and growth inhibition","volume":"13","author":"Mboge","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.111642_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jcp.1040990107","article-title":"T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in\u00a0vitro","volume":"99","author":"Stein","year":"1979","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.111642_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejmech.2019.111642_bib62","first-page":"197","article-title":"Cobalt chloride, a chemical inducer of hypoxia-inducible factor-1a in U251 human glioblastoma cell line","volume":"14","author":"Al Okail","year":"2010","journal-title":"J.\u00a0Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.111642_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the \u03b2-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib64","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/14756366.2011.621122","article-title":"Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds","volume":"27","author":"Ekinci","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14756366.2011.643303","article-title":"Carbonic anhydrase inhibitors: in\u00a0vitro inhibition of \u03b1 isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids","volume":"28","author":"Ekinci","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/14756366.2012.658788","article-title":"Secondary\/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II","volume":"28","author":"Alp","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib67","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.ejmech.2019.111642_bib68","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.ejmech.2019.111642_bib69","series-title":"Schr\u00f6dinger Suite Release 2019-1","year":"2019"},{"key":"10.1016\/j.ejmech.2019.111642_bib70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/chem.201805039","article-title":"Phosphorus versus sulfur: discovery of benzenephosphonamidates as versatile sulfonamide-mimic chemotypes acting as carbonic anhydrase inhibitors","volume":"25","author":"Nocentini","year":"2019","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.111642_bib71","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/14756366.2018.1512597","article-title":"Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms","volume":"33","author":"Nocentini","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111642_bib73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/acsmedchemlett.9b00023","article-title":"\u03b3-Diketocarboxylic acids and their esters act as carbonic anhydrase IX and XII selective inhibitors","volume":"10","author":"Nocentini","year":"2019","journal-title":"ACS Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T12:38:51Z","timestamp":1695127131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419307767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":73,"alternative-id":["S0223523419307767"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111642","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111642"}}